-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AknOFADYczYW6WEt7YIgcLmrywjeOE7YHiAjjTP1RAq/GMjLG9ta39XaG8YntfR0 HjGsuXX3FjB0fOpZjP2c3w== 0001236389-03-000008.txt : 20030827 0001236389-03-000008.hdr.sgml : 20030827 20030827170349 ACCESSION NUMBER: 0001236389-03-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030827 FILED AS OF DATE: 20030827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYSON VAUGHN D CENTRAL INDEX KEY: 0001189539 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19700 FILM NUMBER: 03869132 MAIL ADDRESS: STREET 1: 4709 CREEKSTONE DRIVE STREET 2: STE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0201 4 2003-08-27 0 0000881464 AMYLIN PHARMACEUTICALS INC AMLN 0001189539 BRYSON VAUGHN D 4709 CREEKSTONE DRIVE STE 200 DURHAM NC 27703 1 0 0 0 Phantom Stock Units 2002-07-01 4 A 0 234 9.6 A Common Stock 234 7070 D Phantom Stock Units 2003-01-01 4 A 0 240 16.65 A Common Stock 240 7550 D Phantom Stock Units 2003-04-01 4 A 0 632 15.85 A Common Stock 632 8182 D Phantom Stock-Deferred Compensation 2003-07-08 4 A 0 440 22.52 A Common Stock 440 440 D Conversion or Exercise Price of Derivative security is 1-for-1. The phantom stock units were accrued under the Amylin Pharmaceuticals, Inc. Directors' Deferred Compensation Plan and are to be settled at retirement. Settlement will be paid in cash or stock solely at the Company's discretion. The deemed execution date for this transaction is 7/08/2003. The shares of phantom stock become payable, at the election of the reporting person, upon the earliest to occur of the reporting persons termination of service as a director, the date on which the reporting person reaches 72 years of age, or upon a change in control of the issuer. Vaughn Bryson 2003-08-27 -----END PRIVACY-ENHANCED MESSAGE-----